Your browser doesn't support javascript.
loading
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
Schiller, Gary J; Lipe, Brea C; Bahlis, Nizar J; Tuchman, Sascha A; Bensinger, William I; Sutherland, Heather J; Lentzsch, Suzanne; Baljevic, Muhamed; White, Darrell; Kotb, Rami; Chen, Christine I; Rossi, Adriana; Biran, Noa; LeBlanc, Richard; Grosicki, Sebastian; Martelli, Maurizio; Gunsilius, Eberhard; Spicka, Ivan; Stevens, Don Ambrose; Facon, Thierry; Mesa, Mercedes Gironella; Zhang, Chris; Van Domelen, Dane R; Bentur, Ohad S; Gasparetto, Cristina.
Afiliación
  • Schiller GJ; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. Electronic address: gschiller@mednet.ucla.edu.
  • Lipe BC; University of Rochester, Rochester, NY.
  • Bahlis NJ; Charbonneau Cancer Research Institute, Calgary, AB, Canada; Clinical Research Unit, Tom Baker Cancer Center, Calgary, AB, Canada.
  • Tuchman SA; University of North Carolina, Chapel Hill, NC.
  • Bensinger WI; Swedish Cancer Institute, Seattle, WA.
  • Sutherland HJ; Vancouver General Hospital, Vancouver, BC, Canada.
  • Lentzsch S; Multiple Myeloma and Amyloidosis Service, Columbia University, New York, NY.
  • Baljevic M; Vanderbilt University Medical Center, Nashville, TN.
  • White D; Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada.
  • Kotb R; CancerCare Manitoba, Winnipeg, MB, Canada.
  • Chen CI; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Rossi A; Weill Cornell Medicine, New York, NY.
  • Biran N; Hackensack Meridian Health, Hackensack University Medical Center, Hackensack, NJ.
  • LeBlanc R; Maisonneuve-Rosemont Hospital, University of Montreal, QC, Canada.
  • Grosicki S; Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland.
  • Martelli M; Department of Cellular Biotechnology and Hematology, Hematology Center, Umberto I Polyclinic of Rome, Rome, Italy.
  • Gunsilius E; Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria.
  • Spicka I; First Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic.
  • Stevens DA; Norton Cancer Institute, St. Matthews Campus, Louisville, KY.
  • Facon T; Department of Hematology (Maladies du sang), Hôpital Huriez, CHU, Lille, France.
  • Mesa MG; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Zhang C; Karyopharm Therapeutics Inc., Newton, MA.
  • Van Domelen DR; Karyopharm Therapeutics Inc., Newton, MA.
  • Bentur OS; Karyopharm Therapeutics Inc., Newton, MA.
  • Gasparetto C; Duke University Cancer Center, Durham, NC.
Clin Lymphoma Myeloma Leuk ; 23(9): e286-e296.e4, 2023 09.
Article en En | MEDLINE | ID: mdl-37393120
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mieloma Múltiple / Antineoplásicos Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mieloma Múltiple / Antineoplásicos Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article